ETERNA THERAPEUTICS INC (ERNA)       4.78  -0.06 (-1.24%)

4.78  -0.06 (-1.24%)

US1140822099 - Common Stock

ETERNA THERAPEUTICS INC4.78

NASDAQ:ERNA (1/30/2023, 7:00:02 PM)-0.06 (-1.24%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS Sector Health Care
GICS Industry Biotechnology

Chartmill FA Rating
Valuation Growth
Profitability Health
Dividend

Overview
Earnings (Last) 11-14 2022-11-14/amc Earnings (Next) N/A N/A
Ins Owners 18.92% Inst Owners N/A
Market Cap 14.06M Shares 2.94M
PE N/A Fwd PE N/A
Dividend Yield N/A Analysts 43.33
IPO 08-29 1991-08-29

Stock Screener Links

Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

ERNA Daily chart

Company Profile

Eterna Therapeutics Inc is a US-based company operating in Biotechnology industry. The company is headquartered in Cambridge, Massachusetts and currently employs 10 full-time employees. Eterna Therapeutics Inc. is a biopharmaceutical company. The firm is focused on developing advanced therapies using Messenger RNA (mRNA) cell engineering technology. The firm is engaged in developing medicines to treat various forms of cancer and other diseases with high unmet medical needs. Its product pipeline is based on patented foundational mRNA cell engineering technology and offers multiple clinical applications with future sub-licensing and partnering opportunities. The company formulates mRNA using lipid nanoparticle (LNP) technology. The ToRNAdo delivery system surrounds and protects the mRNA cargo, enabling delivery into human cells. The firm has licensed a portfolio of over 100 patents covering key cell engineering technologies, including therapeutic gene editing in clinical development. The company has multiple cell and gene-editing therapies in preclinical development for various indications.

Company Info

ETERNA THERAPEUTICS INC

1035 Cambridge Street, Suite 18A

Cambridge MASSACHUSETTS

P: 12125821199.0

Employees: 10

Website: https://eternatx.com/

ERNA News

News Image4 days ago - Seeking AlphaEterna Therapeutics chief medical officer to resign (NASDAQ:ERNA)

Roger Sidhu, chief medical officer at Eterna Therapeutics (ERNA), is resigning effective Jan. 31.

News Imagea month ago - Eterna TherapeuticsEterna Therapeutics Appoints Matt Angel, Ph.D. as Chief Executive Officer and President

CAMBRIDGE, Mass., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Eterna Therapeutics Inc. (Nasdaq: ERNA) (“Eterna” or the “Company”), a biopharmaceutical company...

News Image2 months ago - Market News VideoWednesday 12/7 Insider Buying Report: ERNA, GNTYNews Image3 months ago - Eterna TherapeuticsEterna Therapeutics Announces Research Collaboration to Develop Advanced Gene-Edited iPS Cell Therapies

SAN DIEGO, Nov. 01, 2022 (GLOBE NEWSWIRE) -- Eterna Therapeutics Inc. (Nasdaq: ERNA) (“Eterna” or the “Company”), a biopharmaceutical company using...

News Image3 months ago - Eterna Therapeutics Inc.Eterna Therapeutics to Present at iPSC-Derived Immunotherapies Congress

SAN DIEGO, Oct. 18, 2022 (GLOBE NEWSWIRE) -- Eterna Therapeutics Inc. (Nasdaq: ERNA) (“Eterna” or the “Company”), a biopharmaceutical company using...

News Image3 months ago - InvestorPlaceToday’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

It's time for another look at the biggest pre-market stock movers as we check out what's happening with shares on Tuesday morning!

ERNA Twits

Here you can normally see the latest stock twits on ERNA, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example